Akamai CTO sells 3,500 shares at $86 under Rule 10b5-1
Akamai Technologies (AKAM) reported an insider transaction by its Chief Technology Officer.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Akamai Technologies (AKAM) reported an insider transaction by its Chief Technology Officer. On November 7, 2025, the CTO sold 3,500 shares of common stock at $86 per share, coded “S”. The sale was made pursuant to a Rule 10b5-1 plan adopted on March 12, 2025.
Following the transaction, the reporting person beneficially owned 24,410 shares directly. In addition, 64.184 shares were held indirectly by a 401(k) plan, stated as of November 6, 2025.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,500 | $86.00 | $301K |
| Holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Sale was made pursuant to a Rule 10b5-1 Plan adopted by Dr. Blumofe on March 12, 2025.
- F2. As of November 6, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did AKAM report on Form 4?
Who executed the trade and what is their role at AKAM?
Was the sale under a Rule 10b5-1 trading plan?
What transaction code was used in the filing?
Is the ownership direct or indirect after the trade?
AI-generated analysis. How Rhea-AI works. Not financial advice.